Skip to content

Bayer – “Meet the Expert” session: Protection From Babies to Grandparents – Latest Advances in Anticoagulation

Room:

Synergy Auditorium 2

Facilitator:

Abstract:

 

Christoph Male, MD, MSc
Department of Pediatrics and Adolescent Medicine
Medical University of Vienna, Austria
 

 

Learning objectives:

At the end of this session, the participants should:

  • Understand the results from EINSTEIN JUNIOR that established weight-adjusted dosing and showed the efficacy and reassuring safety profile of rivaroxaban for treatment of VTE in children allowing on-label anticoagulation

  • Confirm consistent benefit in vulnerable populations across indications to ensure optimal pharmaceutical care for anticoagulated patients

  • Know how to use rivaroxaban in vulnerable populations: Babies, children, frail patients, renally impaired patients, patients with cancer or diabetes, and very old patients

 

Educational needs addressed:

Hospital pharmacists need to have insights into the new pediatric clinical data and the respective new indication of rivaroxaban. Furthermore, hospital pharmacists need to be informed about effective anticoagulation with rivaroxaban across all indications in children and adults, including high-risk vulnerable patients with cardiovascular diseases to ensure optimal pharmaceutical care for anticoagulated patients.

 

For further questions

 
 
 
×

EAHP Forum

All the EAHP team is working on providing a Forum that can help connect all the members in Conversations and Groups to talk about important matters for the European Hospital Pharmacist.

The Forum will be accessible for all the EAHP members, you don’t have to create a new account to browse and participate.

Conversations and groups

The Conversations will be moderated by our team to provide documents and relevant topics for the community.

The Groups will connect all members that share a category. Members who work on the same assocation, on the same hospital, that have the same role, etc.

Stay tuned for the realase of the forum. Soon on EAHP.